UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance

British journal of cancer, 2021-02, Vol.124 (4), p.770-776

2021

Volltextzugriff (PDF)

Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors

Oncogene, 2020-09, Vol.39 (36), p.5888-5901

2020

Volltextzugriff (PDF)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies

Biomarker research, 2023-03, Vol.11 (1), p.34-34, Article 34

2023

Volltextzugriff (PDF)

Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting

Experimental hematology & oncology, 2024-04, Vol.13 (1), p.43-43, Article 43

2024

Volltextzugriff (PDF)

P803: CRIP1 INDUCES PIS RESISTANCE BY FORMING A COMPLEX WITH USP7/PA200 AND ENHANCING PROTEASOME ACTIVITY AND AUTOPHAGY IN MULTIPLE MYELOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e148499a-n/a

2023

Volltextzugriff (PDF)

When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2411741

2024

Volltextzugriff (PDF)

Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia

Cell death discovery, 2022-04, Vol.8 (1), p.180-180, Article 180

2022

Volltextzugriff (PDF)

SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1

Biomarker research, 2023-06, Vol.11 (1), p.58-58, Article 58

2023

Volltextzugriff (PDF)

Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment

Clinical and translational medicine, 2023-01, Vol.13 (1), p.e1140-n/a

2023

Volltextzugriff (PDF)

Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era

Experimental hematology & oncology, 2023-07, Vol.12 (1), p.66-66, Article 66

2023

Volltextzugriff (PDF)

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma

Blood science, 2023-07, Vol.5 (3), p.196-208

2023

Volltextzugriff (PDF)

CRIP1 Involves the Pathogenesis of Multiple Myeloma Via Dual-Regulation of Proteasome and Autophagy

Blood, 2023-11, Vol.142 (Supplement 1), p.6598-6598

2023

Volltextzugriff (PDF)

Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting

Cancer cell international, 2012-08, Vol.12 (1), p.38-38, Article 38

2012

Volltextzugriff (PDF)

A Questionnaire Analysis of the Awareness of Blood Disease Inpatients and Their Families on Disease and Health Knowledge inside and Outside the Hospital

Blood, 2023-11, Vol.142 (Supplement 1), p.7435-7435

2023

Volltextzugriff (PDF)

2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells

Acta biochimica et biophysica Sinica, 2010-09, Vol.42 (9), p.615-622

2010

Volltextzugriff (PDF)

OA-30 Critical roles of CRIP1 in promoting cell survival and bortezomib resistance by enhancing proteasome activity and autophagy in multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S18-S19

2023

Volltextzugriff (PDF)

A Case of Acute Lymphocytic Leukaemia with t(3;13) and Central Nervous System Leukemia after Allogenic Cord Blood Transplantation

Blood, 2019-11, Vol.134 (Supplement_1), p.5199-5199

2019

Volltextzugriff (PDF)

Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study

Acta oncologica, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-8

2023

Volltextzugriff (PDF)

Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy

Hematology reports, 2009-03, Vol.1 (1), p.4-e4

2009

Volltextzugriff (PDF)

Monitoring for Minimal Residual Disease before and after Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed Acute Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.5735-5735

2019

Volltextzugriff (PDF)

Combination of Four Drugs for Bloodstream Infection Caused By Carbapenem-Resistant Enterobacteriaceae in Severe Agranulocytosis Patients after Hematopoietic Stem Cell Transplantation

Blood, 2019-11, Vol.134 (Supplement_1), p.5664-5664

2019

Volltextzugriff (PDF)

Combination of Haploidentical Hematopoietic with Low-Dose ATG, Ptcy and Cord Blood Competitive Transplantation for Hematologic Malignancies

Blood, 2019-11, Vol.134 (Supplement_1), p.5734-5734

2019

Volltextzugriff (PDF)

When Patients with Plasma Cell Disorders Encountered the Largest Omicron Wave (December 2022) in China: A Real-World Multicenter and Multiregional Study

Blood, 2023-11, Vol.142 (Supplement 1), p.6673-6673

2023

Volltextzugriff (PDF)

Diminished interaction between mutant NOTCH1 and the NuRD corepressor complex upregulates CCL17 in chronic lymphocytic leukemia

Leukemia, 2019-12, Vol.33 (12), p.2951-2956

2019

Volltextzugriff (PDF)

Mutations in the NOTCH1 PEST Domain Enhance the Expression of CCL17 By Displacing the Transcription Factor HDAC1 in Chronic Lymphocytic Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.4408-4408

2018

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(67)
Tagungsberichte
(7)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance

Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies

Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting

P803: CRIP1 INDUCES PIS RESISTANCE BY FORMING A COMPLEX WITH USP7/PA200 AND ENHANCING PROTEASOME ACTIVITY AND AUTOPHAGY IN MULTIPLE MYELOMA

When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study

Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia

SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1

Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment

Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma

CRIP1 Involves the Pathogenesis of Multiple Myeloma Via Dual-Regulation of Proteasome and Autophagy

Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting

A Questionnaire Analysis of the Awareness of Blood Disease Inpatients and Their Families on Disease and Health Knowledge inside and Outside the Hospital

2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells

OA-30 Critical roles of CRIP1 in promoting cell survival and bortezomib resistance by enhancing proteasome activity and autophagy in multiple myeloma

A Case of Acute Lymphocytic Leukaemia with t(3;13) and Central Nervous System Leukemia after Allogenic Cord Blood Transplantation

Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study

Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy

Monitoring for Minimal Residual Disease before and after Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed Acute Leukemia

Combination of Four Drugs for Bloodstream Infection Caused By Carbapenem-Resistant Enterobacteriaceae in Severe Agranulocytosis Patients after Hematopoietic Stem Cell Transplantation

Combination of Haploidentical Hematopoietic with Low-Dose ATG, Ptcy and Cord Blood Competitive Transplantation for Hematologic Malignancies

When Patients with Plasma Cell Disorders Encountered the Largest Omicron Wave (December 2022) in China: A Real-World Multicenter and Multiregional Study

Diminished interaction between mutant NOTCH1 and the NuRD corepressor complex upregulates CCL17 in chronic lymphocytic leukemia

Mutations in the NOTCH1 PEST Domain Enhance the Expression of CCL17 By Displacing the Transcription Factor HDAC1 in Chronic Lymphocytic Leukemia

Suchergebnisse filtern